Literature DB >> 10984726

Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study.

H Wolf1, G M Ecke, S Bettin, J Dietrich, H J Gertz.   

Abstract

OBJECTIVE: White matter lesions on brain CT or MRI are a frequent finding in patients with Alzheimer's disease. However, little is known about the prognostic significance of these changes in cognitively impaired individuals who are at risk for subsequent development of dementia. This study aims at investigating the potential impact of white matter lucencies (WML) on brain CT on the course of mild cognitive impairment. PATIENTS AND METHODS: Twenty-seven patients (mean age 72, SD 4.03) with mild cognitive impairment (MCI) and no signs of cerebrovascular disease were prospectively examined. At their initial presentation, all patients underwent a structured interview for the diagnosis of dementia (SIDAM) and a brain CT. Linear measures of atrophy and visual ratings of white matter changes were performed. At follow-up (mean interval 29 months), these patients were re-examined with the SIDAM. Eight patients had developed dementia and met clinical criteria for Alzheimer's disease (crossover group).
RESULTS: Evaluation of the initial CT scans revealed significantly more frequent and extended white matter abnormalities and a higher degree of temporal lobe atrophy in the crossover group as compared to the cognitively stable group. In the crossover group, high WML severity initially was associated with a lesser degree of temporal lobe atrophy and higher global cognitive performance.
CONCLUSION: We conclude that WML play a role in the dementia process and that they might accelerate cognitive decline in individuals with mild cognitive impairment. WML should be included in prospective studies of MCI as potential predictor variables. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2000        PMID: 10984726     DOI: 10.1002/1099-1166(200009)15:9<803::aid-gps190>3.0.co;2-w

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  31 in total

Review 1.  Contemplating Alzheimer's disease and the contribution of white matter hyperintensities.

Authors:  Adam M Brickman
Journal:  Curr Neurol Neurosci Rep       Date:  2013-12       Impact factor: 5.081

2.  Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts.

Authors:  Sarah Tomaszewski Farias; Dan Mungas; Bruce R Reed; Danielle Harvey; Charles DeCarli
Journal:  Arch Neurol       Date:  2009-09

3.  Executive function mediates effects of white matter hyperintensities on episodic memory.

Authors:  Colleen M Parks; Ana-Maria Iosif; Sarah Farias; Bruce Reed; Dan Mungas; Charles DeCarli
Journal:  Neuropsychologia       Date:  2011-06-13       Impact factor: 3.139

4.  Extent and distribution of white matter hyperintensities in normal aging, MCI, and AD.

Authors:  M Yoshita; E Fletcher; D Harvey; M Ortega; O Martinez; D M Mungas; B R Reed; C S DeCarli
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

Review 5.  Risk factors for the progression of mild cognitive impairment to dementia.

Authors:  Noll L Campbell; Fred Unverzagt; Michael A LaMantia; Babar A Khan; Malaz A Boustani
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

Review 6.  Preventing neurocognitive late effects in childhood cancer survivors.

Authors:  Martha A Askins; Bartlett D Moore
Journal:  J Child Neurol       Date:  2008-10       Impact factor: 1.987

7.  Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.

Authors:  Elisabeth C W van Straaten; Danielle Harvey; Philip Scheltens; Frederik Barkhof; Ronald C Petersen; Leon J Thal; Clifford R Jack; Charles DeCarli
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

8.  Structural neuroimaging in Altheimer's disease: do white matter hyperintensities matter?

Authors:  Adam M Brickman; Jordan Muraskin; Molly E Zimmerman
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

9.  Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

Authors:  C DeCarli; D Mungas; D Harvey; B Reed; M Weiner; H Chui; W Jagust
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

10.  Mediterranean diet and mild cognitive impairment.

Authors:  Nikolaos Scarmeas; Yaakov Stern; Richard Mayeux; Jennifer J Manly; Nicole Schupf; Jose A Luchsinger
Journal:  Arch Neurol       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.